National Institute of Allergy and Infectious Diseases; Notice of Meetings, 50865 [2022-17728]

Download as PDF Federal Register / Vol. 87, No. 159 / Thursday, August 18, 2022 / Notices in accordance with 35 U.S.C. 209 and 37 CFR part 404, as well as for further development and evaluation under a research collaboration. Potential Commercial Applications • Innovative method of treatment for virus-induced lung fibrosis • A multi-targeted approach could decrease lung-term symptoms associated with SARS–CoV–2 Competitive Advantages • Addresses the pathology at the proper location instead of indiscriminately Development Stage • Pre-Clinical Inventors: Peter Sun and Rachel Erickson, all of NIAID. Intellectual Property: US Provisional Application 63/388,498 (HHS Reference No. E–157–2022–0–US–01) filed on 12 July 2022. Licensing Contact: To license this technology, please contact Dawn TaylorMulneix at 301–767–5189, or dawn.taylor-mulneix@nih.gov, and reference E–157–2022. Collaborative Research Opportunity: The National Institute of Allergy and Infectious Diseases is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate or commercialize this technology. For collaboration opportunities, please contact Dawn Taylor-Mulneix at 301– 767–5189, or dawn.taylor-mulneix@ nih.gov. Dated: August 12, 2022. Surekha Vathyam, Deputy Director, Technology Transfer and Intellectual Property Office, National Institute of Allergy and Infectious Diseases. [FR Doc. 2022–17730 Filed 8–17–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health khammond on DSKJM1Z7X2PROD with NOTICES National Institute of Allergy and Infectious Diseases; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of meetings of the National Advisory Allergy and Infectious Diseases Council. The meeting will be open to the public. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov). Individuals who need special VerDate Sep<11>2014 17:42 Aug 17, 2022 Jkt 256001 assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Allergy and Infectious Diseases Council. Date: September 12, 2022. Open: 10:30 a.m. to 11:30 a.m. Agenda: Report of Institute Director. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Virtual Meeting). Closed: 11:45 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Virtual Meeting). Contact Person: Matthew J. Fenton, Ph.D., Director, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F50, Bethesda, MD 20892, 301–496–7291, fentonm@ niaid.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council, Acquired Immunodeficiency Syndrome Subcommittee. Date: September 12, 2022. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Virtual Meeting). Open: 1:00 p.m. to 4:00 p.m. Agenda: Report of Division Director and Division Staff. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Virtual Meeting). Contact Person: Matthew J. Fenton, Ph.D., Director, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F50, Bethesda, MD 20892, 301–496–7291, fentonm@ niaid.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council; Microbiology and Infectious Diseases Subcommittee. Date: September 12, 2022. Closed: 8:30 a.m. to 10:15 a.m. PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 50865 Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Virtual Meeting). Open: 1:00 p.m. to 4:00 p.m. Agenda: Report of Division Director and Division staff. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Virtual Meeting). Contact Person: Matthew J. Fenton, Ph.D., Director, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F50, Bethesda, MD 20892, 301–496–7291, fentonm@ niaid.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council; Acquired Immune Deficiency Syndrome Subcommittee. Date: September 12, 2022. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Virtual Meeting). Open: 1:00 p.m. to 4:00 p.m. Agenda: Report of Division Director and Division Staff. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F30, Rockville, MD 20892 (Virtual Meeting). Contact Person: Matthew J. Fenton, Ph.D., Director, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F50, Bethesda, MD 20892, 301–496–7291, fentonm@ niaid.nih.gov. Any interested person may file written comments within 15 days of the meeting with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.niaid.nih.gov/about/advisory-council, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: August 12, 2022. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–17728 Filed 8–17–22; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\18AUN1.SGM 18AUN1

Agencies

[Federal Register Volume 87, Number 159 (Thursday, August 18, 2022)]
[Notices]
[Page 50865]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-17728]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of meetings of the National Advisory 
Allergy and Infectious Diseases Council.
    The meeting will be open to the public. The open session will be 
videocast and can be accessed from the NIH Videocasting and Podcasting 
website (https://videocast.nih.gov). Individuals who need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council.
    Date: September 12, 2022.
    Open: 10:30 a.m. to 11:30 a.m.
    Agenda: Report of Institute Director.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Virtual Meeting).
    Closed: 11:45 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Matthew J. Fenton, Ph.D., Director, Division of 
Extramural Activities, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council, Acquired Immunodeficiency Syndrome Subcommittee.
    Date: September 12, 2022.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Virtual Meeting).
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of Division Director and Division Staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Matthew J. Fenton, Ph.D., Director, Division of 
Extramural Activities, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council; Microbiology and Infectious Diseases Subcommittee.
    Date: September 12, 2022.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Virtual Meeting).
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of Division Director and Division staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Matthew J. Fenton, Ph.D., Director, Division of 
Extramural Activities, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council; Acquired Immune Deficiency Syndrome Subcommittee.
    Date: September 12, 2022.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Virtual Meeting).
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of Division Director and Division Staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F30, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Matthew J. Fenton, Ph.D., Director, Division of 
Extramural Activities, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].

    Any interested person may file written comments within 15 days 
of the meeting with the committee by forwarding the statement to the 
Contact Person listed on this notice. The statement should include 
the name, address, telephone number and when applicable, the 
business or professional affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: https://www.niaid.nih.gov/about/advisory-council, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 12, 2022.


Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-17728 Filed 8-17-22; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.